中文名稱(chēng)：兔抗TBCC多克隆抗體

英文名稱(chēng)： Anti-TBCC rabbit polyclonal antibody

別名： tubulin folding cofactor C; CFC

相關(guān)類(lèi)別：一抗

儲(chǔ) 存： 冷凍（-20℃）

宿主： Rabbit

抗原： TBCC

反應(yīng)種屬： Human

標(biāo) 記物： Unconjugate

克隆類(lèi)型： rabbit polyclonal

技術(shù)規(guī)格

Background:

Cofactor C is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state.

Applications:

ELISA, IHC

Name of antibody:

TBCC

Immunogen:

Fusion protein of human TBCC

Full name:

tubulin folding cofactor C

Synonyms:

CFC

SwissProt:

Q15814

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human prostate cancer

IHC Recommend dilution:

100-200

展開(kāi)全部

兔抗TBCC多克隆抗體說(shuō)明書(shū)
下載

久久综合九九-久久综合九九亚洲一区-久久综合九色-久久综合九色欧美综合狠狠-久久综合九色婷婷97-久久综合九色综合8888

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細(xì)胞系

細(xì)胞庫(kù)

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細(xì)胞

細(xì)胞專(zhuān)用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標(biāo)準(zhǔn)品

血清

形態(tài)病理檢測(cè)

分子病理

超微病理

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗TBCC多克隆抗體

Background:	Cofactor C is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state.
Applications:	ELISA, IHC
Name of antibody:	TBCC
Immunogen:	Fusion protein of human TBCC
Full name:	tubulin folding cofactor C
Synonyms:	CFC
SwissProt:	Q15814
ELISA Recommended dilution:	5000-10000
IHC positive control:	Human prostate cancer
IHC Recommend dilution:	100-200